100% correct than the shorts post al over media it

100% correct than the shorts post al over media it’s not the shorts it’s weak hands it’s longs it’s everyone but shorts. Ya ok. It’s ridiculous taht the stock was 5+ for quite some time almost 5 months ago, we were 5 months further from the finish line, we had 95% of our competitors since then fail for safety reasons, no positive effects halt trials inefficiency, we have made it through 2 DSMC reviews, we are all if we with UK, Philippines and prob Canada and a few others in the works. This was just a big promising hope to get a Covid-19 approval or EUA. I know we would get an EUA the day after we were to release our cd-12 trial data but we are so close to full approval and than leronlomab could be used off label to help save so many other people in different indications and that’s the pot of gold at the end of the rainbow. It’s days like today that I would have jumped in an d been more than happy loading up on more shares in the $1.70 range but I was at dentist during the short attack was
Already back to $1.90 when I was out.